NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 11.4% on 5/2/24. The shares closed at $14.19. Trading volume in this advance was normal. The stock has been extremely weak relative to the market over the last nine months but has risen 15.0% during the last week.
Current PriceTarget Research Rating
NVCR’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. NovoCure has a poor Power Rating of 28 and a very low Appreciation Score of 10, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment